Market Overview

Benzinga's Top Initiations

Share:
Related THLD
Cantor Still Expects Threshold Pharma To More Than Triple, Says 2016 Will Be 'Data Rich' Year
5 New Biotech Developments Worth Watching
Threshold Pharmaceuticals Announces Presentation and Webcast at the Cantor Fitzgerald ... (GuruFocus)
Related ANV
Heron Therapeutics Initiates Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative Pain
Top Performing Industries For January 27, 2015

Analysts at William Blair initiated coverage on shares of Threshold Pharmaceuticals (NASDAQ: THLD) with an “outperform” rating. Threshold Pharmaceuticals' shares closed at $8.15 yesterday. Threshold Pharmaceuticals had $49.73 million in total cash for the latest quarter.

Scotia Capital initiated coverage on shares of Allied Nevada Gold (AMEX: ANV) with an “outperform” rating. Allied Nevada Gold's stock closed at $28.08 yesterday. Allied Nevada Gold's trailing-twelve-month operating margin is 35.98%.

JMP Securities initiated coverage on shares of Darling International (NYSE: DAR) with a “market perform” rating. Darling's shares closed at $16.18 yesterday. Darling's trailing-twelve-month revenue is $1.74 billion.

Analysts at Roth Capital initiated coverage on shares of Harmonic (NASDAQ: HLIT) with a “neutral” rating. Harmonic's shares closed at $4.21 yesterday. Harmonic's PEG ratio is 1.41.

Latest Ratings for THLD

DateFirmActionFromTo
Sep 2014Cantor FitzgeraldInitiates Coverage onBuy
Sep 2014HC WainwrightInitiates Coverage onBuy
Feb 2013Piper JaffrayUpgradesNeutralOverweight

View More Analyst Ratings for THLD
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ANV + DAR)

Around the Web, We're Loving...

Get Benzinga's Newsletters